Preclinical Toxicology
A key consideration for preclinical toxicology studies for cell and gene therapy is the inclusion of a toxicology study design that mimics the proposed clinical trial design as closely as possible. Mitigate risks and avoid setbacks with an experienced team of toxicologists, skilled study directors, pathologists, veterinarians, surgeons, regulatory specialists, and support personnel.